Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

Abstract Background Response to modern treatment strategies, which combine cytotoxic compounds with immune stimulatory agents and targeted treatment is highly variable among MCL patients. Thus, providing prognostic and predictive markers for risk adapted therapy is warranted and molecular informatio...

Full description

Bibliographic Details
Main Authors: Lavanya Lokhande, Venera Kuci Emruli, Arne Kolstad, Martin Hutchings, Riikka Räty, Mats Jerkeman, Sara Ek
Format: Article
Language:English
Published: BMC 2020-12-01
Series:BMC Cancer
Subjects:
Mantle cell lymphoma (MCL)
Serum proteins
Biomarker discovery
Protein signature
Online Access:https://doi.org/10.1186/s12885-020-07678-4

Internet

https://doi.org/10.1186/s12885-020-07678-4

Similar Items